FDA Greenlights First Motion Sickness Drug in More Than 40 Years

(MedPage Today) — The FDA has approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent movement-induced vomiting in adults, Vanda Pharmaceuticals announced Tuesday. This approval marks the first new drug treatment…